Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which clinical trials are currently being monitored by NHS England’s national specialised commissioning team to assess the evidence base for the use of Stereotactic Ablative Radiotherapy to treat early non-small cell lung cancer.
NHS England has routinely commissioned stereotactic ablative radiotherapy to treat early non-small cell lung cancer since 2013, meaning that the evidence to support its routine commissioning has already been established for patients that meet the eligibility criteria described in the clinical commissioning policy. NHS England has since reviewed the clinical evidence for later stage non-small cell lung cancer and all stages of small cell lung cancer and a second policy is in development.